Copyright
©2010 Baishideng. All rights reserved.
World J Gastrointest Pharmacol Ther. Feb 6, 2010; 1(1): 1-2
Published online Feb 6, 2010. doi: 10.4292/wjgpt.v1.i1.1
Published online Feb 6, 2010. doi: 10.4292/wjgpt.v1.i1.1
What is the purpose of launching World Journal of Gastrointestinal Pharmacology and Therapeutics?
Lian-Sheng Ma, Beijing Baishideng BioMed Scientific Co., Ltd., Room 903, Building D, Ocean International Center, No. 62 Dongsihuan Zhonglu, Chaoyang District, Beijing 100025, China
Author contributions: Ma LS solely contributed to this paper.
Correspondence to: Lian-Sheng Ma, Professor, President and Editor-in-Chief, Beijing Baishideng BioMed Scientific Co., Ltd., Room 903, Building D, Ocean International Center, No. 62 Dongsihuan Zhonglu, Chaoyang District, Beijing 100025, China. l.s.ma@wjgnet.com
Telephone: +86-10-59080036 Fax: +86-10-85381893
Received: July 21, 2009
Revised: August 13, 2009
Accepted: August 20, 2009
Published online: February 6, 2010
Revised: August 13, 2009
Accepted: August 20, 2009
Published online: February 6, 2010
Abstract
The first issue of World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT), whose preparatory work was initiated on September 27, 2008, will be published on February 6, 2010. The WJGPT Editorial Board has now been established and consists of 188 distinguished experts from 36 countries. Our purpose of launching WJGPT is to publish peer-reviewed, high-quality articles via an open-access online publishing model, thereby acting as a platform for communication between peers and the wider public, and maximizing the benefits to editorial board members, authors and readers.
Keywords: Maximization of personal benefits; Editorial board members; Authors; Readers; Employees; World Journal of Gastrointestinal Pharmacology and Therapeutics